These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17635698)

  • 1. Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin.
    Fortenberry YM; Whinna HC; Cooper ST; Myles T; Leung LL; Church FC
    J Thromb Haemost; 2007 Jul; 5(7):1486-92. PubMed ID: 17635698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
    Cooper ST; Rezaie AR; Esmon CT; Church FC
    Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombomodulin enhances the reactivity of thrombin with protein C inhibitor by providing both a binding site for the serpin and allosterically modulating the activity of thrombin.
    Yang L; Manithody C; Walston TD; Cooper ST; Rezaie AR
    J Biol Chem; 2003 Sep; 278(39):37465-70. PubMed ID: 12878585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex.
    Rezaie AR; Cooper ST; Church FC; Esmon CT
    J Biol Chem; 1995 Oct; 270(43):25336-9. PubMed ID: 7592694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
    Rezaie AR
    Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
    Rezaie AR
    Biochemistry; 1999 Nov; 38(44):14592-9. PubMed ID: 10545182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex.
    Li W; Adams TE; Nangalia J; Esmon CT; Huntington JA
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4661-6. PubMed ID: 18362344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
    Neese LL; Wolfe CA; Church FC
    Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
    Whinna HC; Church FC
    J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mapping of the thrombin-heparin cofactor II complex.
    Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC
    J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of protein C inhibitor activity.
    Neese LL; Pratt CW; Church FC
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):737-46. PubMed ID: 7532447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin.
    Rezaie AR; Yang L
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12051-6. PubMed ID: 14523228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator.
    Hayashi T; Nishioka J; Nakagawa N; Kamada H; Gabazza EC; Kobayashi T; Hattori A; Suzuki K
    J Thromb Haemost; 2007 Jul; 5(7):1477-85. PubMed ID: 17456194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
    Myles T; Church FC; Whinna HC; Monard D; Stone SR
    J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heparin binding site of protein C inhibitor is protease-dependent.
    Li W; Huntington JA
    J Biol Chem; 2008 Dec; 283(51):36039-45. PubMed ID: 18974053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity.
    Phillips JE; Cooper ST; Potter EE; Church FC
    J Biol Chem; 1994 Jun; 269(24):16696-700. PubMed ID: 8206990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
    Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
    J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101.
    Ye J; Rezaie AR; Esmon CT
    J Biol Chem; 1994 Jul; 269(27):17965-70. PubMed ID: 8027055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
    Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
    Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.